Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 10/2009

01-10-2009 | Reviews

Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours

Authors: Ma. José Serrano Fernández, Juan Carlos Álvarez Merino, Iñigo Martínez Zubiaurre, Ana Fernández García, Pedro Sánchez Rovira, José Antonio Lorente Acosta

Published in: Clinical and Translational Oncology | Issue 10/2009

Login to get access
Metadata
Title
Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours
Authors
Ma. José Serrano Fernández
Juan Carlos Álvarez Merino
Iñigo Martínez Zubiaurre
Ana Fernández García
Pedro Sánchez Rovira
José Antonio Lorente Acosta
Publication date
01-10-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 10/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0421-z

Other articles of this Issue 10/2009

Clinical and Translational Oncology 10/2009 Go to the issue

Educational Series

Prognostic and predictive factors and genetic analysis of early breast cancer

Research Articles

Radiosurgery and whole brain therapy in the treatment of brainstem metastases

Editorial

ECCO 15: 34th ESMO Multidisciplinary Congress in Berlin: a step forward to a high-quality global oncology forum

Research Articles

Loco-regional control after postoperative radiotherapy for patients with regional nodal metastases from melanoma

Case Reports

Extrapulmonary small cell carcinoma in breast and prostate

Educational Series

Adding more content to screening: reactivation of FOXO as a therapeutic strategy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits